ANAB:NASDAQ, AnaptysBio, Inc.

ANAB stock overview

AnaptysBio, Inc. (ANAB:NASDAQ) closed at $45.73 on November 16, 2026, down 1.12% on the day. The stock trades 36.8% below its 52-week high of $72.36 and 107.8% above its 52-week low of $22.01. Over the past year, it gained 97.3%. AnaptysBio, Inc. is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price
$45.73
Day change
-1.12%
Volume
483,756
Average volume
479,632
Market cap
1B+
52-week range
$22.01 – $72.36
50-day average
$49.79
200-day average
$51.20

Price action over the past year

In 252 trading sessions since November 14, 2025, ANAB closed higher on 129 days (51%). Its best day was April 24, 2026 (+14.84%) and its worst was July 20, 2026 (-13.29%). The stock moved 10% or more in a single session 8 times.

Recent signals

ANAB news

About AnaptysBio, Inc.

AnaptysBio Inc is a biotechnology company. The Company is engaged in developing first-in-class antibody product candidates focused on unmet medical needs in inflammation and immuno-oncology. Its product include ANB020 and ANB019.

Similar stocks

Find more stocks like ANAB with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.